News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Health Care Delivery

Latest News

May 27th 2016

Examining Cardiovascular Outcomes Trials

GLP-1 Receptor Agonists and Cardiovascular Benefit

Understanding the Safety Data in CANVAS

Practical Implications of the CANVAS Trial

Diabetes: Shifting Mindset for Cardiovascular Benefits

CME Content

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Complexities in Diabetes Care in 2017

May 27th 2016

The Potential Role of PCSK9 Inhibitors for Patients With Hyperlipidemia

May 27th 2016

Role of the Health Plan in Providing Support to Members With Diabetes

May 27th 2016

The Role of PCSK9 Inhibitors for Patients with Hyperlipidemia

May 27th 2016

An Increased Emphasis on Individual Risk Factors and Goals

May 27th 2016

Impact of Cost on Patients' Access to Treatment

May 27th 2016

How Drug Cost Influences Drug Selection

May 27th 2016

Role of Early Intervention in Preventing Progression to T2D

May 27th 2016

Major Cost Drivers in T2D Management

May 27th 2016

Updates to Treatment Guidelines: Effects on Payers

May 27th 2016

Advantages of Medications that Treat Multiple Conditions

May 27th 2016

Management of Hyperlipidemia in Patients With Liver Impairment or Renal Impairment

May 27th 2016

Considerations Regarding Statin Therapy

May 27th 2016

Role of Clinical Practice Guidelines in the Management of Diabetes and Diabetes-Related Complications

May 27th 2016

Addressing the Effect of Polypharmacy on Medication Adherence

May 27th 2016

The Role of Managed Care in Identifying and Counseling Patients With Prediabetes

May 27th 2016

Partnering With Providers to Prevent or Delay Complications Related to Diabetes

May 27th 2016

WellCare's Initiatives To Improve Care for Members With Diabetes

May 27th 2016

Alternatives to Add-On Therapy for T2D and Hyperlipidemia

May 27th 2016

The Influence of Lipid Guidelines on Real-World Practice Patterns

May 27th 2016

Variables Involved When Adding Medications to Treat Diabetes

May 27th 2016

How Does the Potential for Weight Gain Influence Choice of Therapies?

May 27th 2016

Comparison of Guidelines From ADA and AACE

May 27th 2016

Complications of Diabetes and Role of Insulin Resistance in Metabolic Syndrome

May 27th 2016

BMS Piqued by ICER's HTA Report on New Myeloma Drugs, Publishes Response

BySurabhi Dangi-Garimella, PhD

May 26th 2016

Bristol-Myers Squibb has challenged the recently released report by the Institute for Clinical and Economic Review that evaluates the clinical and cost effectiveness of newer treatments for multiple myeloma.

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Exploring Identity, Appearance Experiences Among Patients With Alopecia

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Real-World Evidence Backs Acalabrutinib in CLL Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text